167 related articles for article (PubMed ID: 36161355)
1. ILC3-like ILC2 subset increases in minimal persistent inflammation after acute type II inflammation of allergic rhinitis and inhibited by Biminkang: Plasticity of ILC2 in minimal persistent inflammation.
Chen XJ; Liu C; Zhang S; Zhang LF; Meng W; Zhang X; Sun M; Zhang Y; Wang RZ; Yao CF
J Leukoc Biol; 2022 Dec; 112(6):1445-1455. PubMed ID: 36161355
[TBL] [Abstract][Full Text] [Related]
2. Bimin Kang ameliorates the minimal persistent inflammation in allergic rhinitis by reducing BCL11B expression and regulating ILC2 plasticity.
Qi LJ; Gao S; Ning YH; Chen XJ; Wang RZ; Feng X
J Ethnopharmacol; 2024 Jun; 333():118454. PubMed ID: 38852638
[TBL] [Abstract][Full Text] [Related]
3. Gata3 drives development of RORγt+ group 3 innate lymphoid cells.
Serafini N; Klein Wolterink RG; Satoh-Takayama N; Xu W; Vosshenrich CA; Hendriks RW; Di Santo JP
J Exp Med; 2014 Feb; 211(2):199-208. PubMed ID: 24419270
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of lower airway inflammatory changes in the minimal persistent inflammation of allergic rhinitis in mice.
Xu J; Gao L; Yao H; Zhang R; Liu N; Wang L; Liu E; Dai J; Fu Z
J Asthma; 2018 Nov; 55(11):1187-1196. PubMed ID: 29278941
[TBL] [Abstract][Full Text] [Related]
5. Inhibited interleukin 35 expression and interleukin 35-induced regulatory T cells promote type II innate lymphoid cell response in allergic rhinitis.
Liu W; Zeng Q; Wen Y; Tang Y; Yan S; Li Y; Zhou L; Luo R
Ann Allergy Asthma Immunol; 2021 Feb; 126(2):152-161.e1. PubMed ID: 32771356
[TBL] [Abstract][Full Text] [Related]
6. Effects of Blocking NLRP3 Inflammasome on Type II Innate Lymphoid Cell Response in Allergic Rhinitis.
Gong G; Huang P; Yang C; Huang C; Zhang Z; Chen R; Sun T; Yang G
Iran J Immunol; 2023 Sep; 3(20):287-302. PubMed ID: 37583131
[TBL] [Abstract][Full Text] [Related]
7. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
[TBL] [Abstract][Full Text] [Related]
8. Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis.
Piao CH; Song CH; Lee EJ; Chai OH
Chem Biol Interact; 2020 Jan; 315():108874. PubMed ID: 31669322
[TBL] [Abstract][Full Text] [Related]
9. Analysis of expression of ILC2 cells in nasal mucosa based on animal model of allergic bacterial infection rhinitis.
Liu Z; Yang X; Liu X; Mu Y; Wang L; Song X; Zhang H
J Infect Public Health; 2021 Jan; 14(1):77-83. PubMed ID: 31753724
[TBL] [Abstract][Full Text] [Related]
10. Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3.
Tachó-Piñot R; Stamper CT; King JI; Matei-Rascu V; Richardson E; Li Z; Roberts LB; Bassett JW; Melo-Gonzalez F; Fiancette R; Lin IH; Dent A; Harada Y; Finlay C; Mjösberg J; Withers DR; Hepworth MR
Cell Rep; 2023 Nov; 42(11):113425. PubMed ID: 37950867
[TBL] [Abstract][Full Text] [Related]
11. Iloprost inhibits acute allergic nasal inflammation by GATA3 -ILC2 pathway in mice.
Liu J; Jiang X; Li L; Liu H; Zhang X; Liu K; Yang C
Respir Physiol Neurobiol; 2020 May; 276():103364. PubMed ID: 31899354
[TBL] [Abstract][Full Text] [Related]
12. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score.
Jeffery HC; McDowell P; Lutz P; Wawman RE; Roberts S; Bagnall C; Birtwistle J; Adams DH; Oo YH
PLoS One; 2017; 12(12):e0188649. PubMed ID: 29261670
[TBL] [Abstract][Full Text] [Related]
13. Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model.
Quan SH; Zhang YL; Han DH; Iwakura Y; Rhee CS
Ann Allergy Asthma Immunol; 2012 May; 108(5):342-50. PubMed ID: 22541406
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-155 plays critical effects on Th2 factors expression and allergic inflammatory response in type-2 innate lymphoid cells in allergic rhinitis.
Zhu YQ; Liao B; Liu YH; Wang Z; Zhu XH; Chen XB; Wang MQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4097-4109. PubMed ID: 31173279
[TBL] [Abstract][Full Text] [Related]
15. Type 3 innate lymphoid cell: a new player in liver fibrosis progression.
Wang S; Li J; Wu S; Cheng L; Shen Y; Ma W; She W; Yang C; Wang J; Jiang W
Clin Sci (Lond); 2018 Dec; 132(24):2565-2582. PubMed ID: 30459204
[TBL] [Abstract][Full Text] [Related]
16. CD4
Lin L; Chen Z; Dai F; Wei JJ; Tang XY; Sun GB
Auris Nasus Larynx; 2019 Aug; 46(4):533-541. PubMed ID: 30554982
[TBL] [Abstract][Full Text] [Related]
17. Innate Lymphoid Cells and Intestinal Inflammatory Disorders.
Zheng M; Zhu J
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163778
[TBL] [Abstract][Full Text] [Related]
18. Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps.
Poposki JA; Klingler AI; Tan BK; Soroosh P; Banie H; Lewis G; Hulse KE; Stevens WW; Peters AT; Grammer LC; Schleimer RP; Welch KC; Smith SS; Conley DB; Raviv JR; Karras JG; Akbari O; Kern RC; Kato A
Immun Inflamm Dis; 2017 Sep; 5(3):233-243. PubMed ID: 28474861
[TBL] [Abstract][Full Text] [Related]
19. STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection.
Stier MT; Goleniewska K; Cephus JY; Newcomb DC; Sherrill TP; Boyd KL; Bloodworth MH; Moore ML; Chen K; Kolls JK; Peebles RS
J Immunol; 2017 Jul; 199(2):510-519. PubMed ID: 28576981
[TBL] [Abstract][Full Text] [Related]
20. Age-Related Dynamics of Circulating Innate Lymphoid Cells in an African Population.
Darboe A; Nielsen CM; Wolf AS; Wildfire J; Danso E; Sonko B; Bottomley C; Moore SE; Riley EM; Goodier MR
Front Immunol; 2020; 11():594107. PubMed ID: 33343571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
